Patrik Eschricht
PHI stärker sin närvaro i Asien genom Gaia Bioscience
Phase Holographic Imaging (PHI) stärker sin globala närvaro genom valet av Gaia Bioscience som ny distributör i Singapore och...
Intervju
PHI accelerates growth with record order
Phase Holographic Imaging recently received its most significant...
Intervju
PHI’s CEO comments on the approved US listing
Phase Holographic Imaging has been approved for a...
Intervju
PHI grows its network of collaborations
Phase Holographic Imaging has entered into a partnership...
Intervju
PHI: “It’s the right moment to capitalize on regenerative medicine momentum”
Medtech company Phase Holographic Imaging recently secured a...
Intervju
Shift to regenerative medicine increases growth prospects for PHI
With a sharp focus on expanding its market...
Intervju
PHI: ”We aim to revolutionize the regenerative medicine market ”
A year ago, Patrik Eschricht assumed the role...
Intervju
PHI’s CEO reflects on the Company’s momentum
Medtech company PHI has experienced a dynamic year,...
Intervju
PHI links up with two regenerative medicine networks
In 2023, Phase Holographic Imaging has solidified its...
Intervju
PHI charts a bold course to impact regenerative medicine
Swedish medtech company PHI released its year-end report...
Intervju
PHI’s CEO reflects on global roadshow success
During the early summer, medical technology company PHI...
Intervju
PHI on how TO 3 proceeds will be used
On May 2, the redemption period of Phase...
Intervju
